- decreased circulating HDL cholesterol level / IMPC
- increased mean platelet volume / IMPC
- decreased circulating triglyceride level / IMPC
- decreased hemoglobin content / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating bilirubin level / IMPC
- increased red blood cell distribution width / IMPC
C57BL/6N-C2cd4bem1(IMPC)Wtsi/WtsiKieg
Status | Available to order |
EMMA ID | EM:13545 |
International strain name | C57BL/6N-C2cd4bem1(IMPC)Wtsi/WtsiKieg |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | C2cd4bem1(IMPC)Wtsi |
Gene/Transgene symbol | C2cd4b |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Karolinska Institutet, Stockholm, Sweden |
Animals used for archiving | heterozygous C57BL/6N |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating triglyceride level / IMPC
- decreased circulating cholesterol level / IMPC
- increased mean platelet volume / IMPC
- increased circulating bilirubin level / IMPC
- increased red blood cell distribution width / IMPC
- decreased hemoglobin content / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).